TD Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $429K | Buy |
|
|||||
|
2025
Q1 | $1.09M | Sell |
|
|||||
|
2024
Q4 | $2.24M | Buy |
|
|||||
|
2024
Q3 | $3.28M | Sell |
|
|||||
|
2024
Q2 | $3.84M | Buy |
|
|||||
|
2024
Q1 | $4.18M | Buy |
|
|||||
|
2023
Q4 | $4.64M | Buy |
|
|||||
|
2023
Q3 | $2.3M | Buy |
|
|||||
|
2023
Q2 | $1.11M | Buy |
|
|||||
|
2023
Q1 | $684K | Sell |
|
|||||
|
2022
Q4 | $826K | Buy |
|
|||||
|
2022
Q3 | $465K | Sell |
|
|||||
|
2022
Q2 | $911K | Hold |
|
|||||
|
2022
Q1 | $1.05M | Hold |
|
|||||
|
2021
Q4 | $1.45M | Sell |
|
|||||
|
2021
Q3 | $2.48M | Hold |
|
|||||
|
2021
Q2 | $2.97M | Sell |
|
|||||
|
2021
Q1 | $3.95M | Buy |
|
|||||
|
2020
Q4 | $4.36M | Buy |
|
|||||
|
2020
Q3 | $1.42M | Buy |
|
|||||
|
2020
Q2 | $821K | Hold |
|
|||||
|
2020
Q1 | $547K | Sell |
|
|||||
|
2019
Q4 | $1.1M | Buy |
|
|||||
|
2019
Q3 | $435K | Buy |
|
|||||
|
2019
Q2 | $437K | Buy |
|
|||||
|
2019
Q1 | $420K | Sell |
|
|||||
|
2018
Q4 | $374K | Buy |
|
|||||
|
2018
Q3 | $505K | Hold |
|
|||||
|
2018
Q2 | $402K | Buy |
|
|||||
|
2018
Q1 | $379K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $251K | Sell |
|
|||||
|
2016
Q3 | $395K | Buy |
|
|||||
|
2016
Q2 | $237K | Sell |
|
|||||
|
2016
Q1 | $238K | Sell |
|
|||||
|
2015
Q4 | $376K | Sell |
|
|||||
|
2015
Q3 | $392K | Buy |
|